Industry News

Transparency Life Sciences Awarded $1.4 Million NCATS SBIR Grant To Conduct Innovative Trial Of Lisinopril In Multiple Sclerosis --Phase 2a Trial is First to Use Crowdsourcing for Protocol Design and Telemonitoring for Patient Data Collection----AMC Healt
Sosei Group Announces Positive Results for Ultibro� and Seebri� Presented at ERS 2014, and Promotion Agreement with Pfizer in the UK
Herantis Pharma announces FDA clearance of IND for Phase 2 study of Cis-UCA Eye Drops
FDA Director for Diagnostic Tests to Discuss the Agency's Proposed Framework to Oversee Laboratory Developed Tests
Herantis Pharma announces FDA clearance of IND for Phase 2 study of Cis-UCA Eye Drops
Actinium Files Orphan Drug Application for Actimab-A
Basilea's partner Astellas receives notification from U.S. FDA of acceptance of filing of isavuconazole NDA for the treatment of invasive aspergillosis and invasive mucormycosis
Lundbeck: Northera Capsules Now Available in U.S.
ACT Gets Its Act Right, HART Given Privileged Status, FDA Nod Fails To Lift KERX
Researchers edging closer to potential valley fever cure
Lundbeck: Northera Capsules Now Available in U.S.
Acadia Pharmaceuticals: FDA Grants Trade Name Nuplazid for Pimavanserin
Covidien Acquires Sapheon
Marathon Pharmaceuticals Launches ZiNGO� (lidocaine hydrochloride monohydrate) Powder Intradermal Injection System, Topical Local Anesthetic to Manage Venous Access Pain
VentiRx Pharmaceuticals Announces Fast Track Designation Granted for Motolimod (VTX-2337), a Novel Immunotherapy for Women with Ovarian Cancer
Ligand Pharmaceuticals: FDA to OK GlaxoSmithKline Promacta/Revolade
Propeller Health Raises $14.5 Million Series B Financing Led by Safeguard Scientifics Company to scale FDA-cleared digital therapeutic to tackle $100 billion cost of treating asthma and chronic obstructive pulmonary disease (COPD)
U.S. Expediting Zmapp Production, Contracts Services Drug Producer
Arena Pharmaceuticals' APD811 Granted Orphan Drug Status for Pulmonary Arterial Hypertension
DPT Laboratories Acquires Meda Pharmaceuticals Lakewood, New Jersey, Location
U.S. court orders Takeda to pay $6 billion over Actos diabetes drug
Canada's Lawson Health Research Institute Investigates Groundbreaking New Technology to Monitor Cerebral Blood Flow in Cardiac Surgery Patients
Merck's Investigational Beta-lactamase Inhibitor Relebactam Granted QIDP and Fast Track Designations
Salix Submits Response to XIFAXAN 550mg Complete Response Letter Regarding Repeat Treatment for Irritable Bowel Syndrome with Diarrhea
Propeller Health Raises $14.5 Million to tackle asthma and chronic obstructive pulmonary disease